{
  "meta": {
    "title": "16_Renin-Angiotensin-Aldosterone_System",
    "url": "https://brainandscalpel.vercel.app/16-renin-angiotensin-aldosterone-system-7f54f6d7.html",
    "scrapedAt": "2025-11-30T12:34:09.521Z"
  },
  "questions": [
    {
      "text": "Which of the following ACE inhibitors is not a prodrug?",
      "choices": [
        {
          "id": 1,
          "text": "Fosinopril"
        },
        {
          "id": 2,
          "text": "Enalapril"
        },
        {
          "id": 3,
          "text": "Ramipril"
        },
        {
          "id": 4,
          "text": "Lisinopril"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Lisinopril</strong> is not a prodrug.</p>\n<p>All ACE inhibitors are prodrugs except lisinopril and <strong>captopril.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4694",
      "difficulty": "medium"
    },
    {
      "text": "A patient with BP 225/145 presents with acute pulmonary edema and is diagnosed with hypertensive emergency. The active metabolite of which ACE inhibitor is available for intravenous use in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Ramipril"
        },
        {
          "id": 2,
          "text": "Perindopril"
        },
        {
          "id": 3,
          "text": "Enalapril"
        },
        {
          "id": 4,
          "text": "Fosinopril"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Enalapril </strong>is available in its active form as<strong> enalaprilat </strong>for <strong>intravenous </strong>use<strong>.</strong></p>\n<p>Enalapril is a <strong>prodrug</strong> of enalaprilat. It is indicated in conditions where oral drugs cannot be used or rapid onset of action is desired like in a case of <strong>hypertensive emergency</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2148",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements regarding ACE inhibitors is true?",
      "choices": [
        {
          "id": 1,
          "text": "They inhibit the conversion of angiotensinogen to angiotensin I"
        },
        {
          "id": 2,
          "text": "Omission of prior diuretic dose decreases the risk of postural hypotension"
        },
        {
          "id": 3,
          "text": "Lisinopril is shorter acting than enalapril"
        },
        {
          "id": 4,
          "text": "They are contraindicated in diabetic patients"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>omission</strong> of prior <strong>diuretic</strong> dose <strong>decreases</strong> the risk of<strong> postural hypotension</strong>.</p>\n<p><strong>ACE inhibitors</strong> cause arteriolar dilation and increase the compliance of larger arteries. ACE inhibitors induced hypotension is thereby due to a<strong> decrease in total peripheral resistance</strong>. In <strong>diuretic-treated</strong> patients, the <strong>renin-angiotensin-aldosterone system</strong> is more active to <strong>compensate for volume loss</strong>. Hence, <strong>ACE inhibitors</strong> increase the risk of <strong>postural hypotension</strong> in these patients.&nbsp;</p>\n<p>Option A: ACE inhibitors inhibit the conversion of <strong>angiotensin I </strong>to<strong> angiotensin II.</strong></p>\n<p>Option C: Lisinopril is <strong>longer acting</strong> than enalapril. Lisinopril is usually <strong>administered once daily</strong> in all patients. Enalapril requires twice-daily administration in some patients.</p>\n<p>Option D: ACE inhibitors and ARBs are <strong>first-line</strong> agents in <strong>diabetic patients </strong>because of their<strong> renoprotective</strong> effects.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4695",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are indications for the use of ACE inhibitors except:",
      "choices": [
        {
          "id": 1,
          "text": "Hypertensive emergency"
        },
        {
          "id": 2,
          "text": "Myocardial infarction"
        },
        {
          "id": 3,
          "text": "Left ventricular dysfunction"
        },
        {
          "id": 4,
          "text": "Pheochromocytoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>ACE inhibitors are usually avoided in conditions like <strong>pheochromocytoma</strong> which is associated with&nbsp;<strong>high renin</strong> activity. <strong>Abrupt inhibition</strong> of the <strong>RAAS</strong> system can result in <strong>severe hypotension</strong> (usually postural).</p>\n<div class=\"page\" title=\"Page 229\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The majority of pheochromocytomas are treated surgically. <strong>Phenoxybenzamine</strong> is often used in preparing the patient for <strong>surgery</strong> and also to manage hypertension in inoperable or malignant pheochromocytoma. <strong>Phentolamine</strong> can also be used in the short-term control of hypertension in these patients.</p>\n</div>\n</div>\n</div>\n</div>\n<p>ACE inhibitors are indicated in hypertensive emergency, myocardial infarction, and left ventricular dysfunction.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4708",
      "difficulty": "easy"
    },
    {
      "text": "In which of the following patients are ACE inhibitors not contraindicated?<div class='question-desc-html'><ol>\n<li>A 23-year-old primigravid woman with preeclampsia</li>\n<li>A 50-year-old man with unilateral renal artery stenosis</li>\n<li>A 50-year-old man with bilateral renal artery stenosis</li>\n<li>A post-myocardial infarction patient with left ventricular systolic dysfunction</li>\n<li>A patient with scleroderma renal crisis</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 3"
        },
        {
          "id": 2,
          "text": "1,2 and 3"
        },
        {
          "id": 3,
          "text": "2,4 and 5"
        },
        {
          "id": 4,
          "text": "3, 4 and 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>ACE inhibitors are not contraindicated in unilateral renal artery stenosis, left ventricular systolic dysfunction, and scleroderma renal crisis.</p>\n<p>Patient 1: ACE inhibitors are <strong>teratogenic</strong> and can cause hypoplasia of organs, renal failure, anuria, and growth retardation in the fetus. Therefore, they are <strong>contraindicated </strong>in<strong> pregnancy.&nbsp;</strong></p>\n<p>Patient 2: ACE inhibitors&nbsp;can be used with caution in unilateral renal artery stenosis if the other kidney is functioning normally.</p>\n<p>Patient 3: Efferent arteriolar constriction maintains the glomerular filtration pressure in <strong>bilateral renal artery stenosis</strong>. ACE inhibitors are <strong>contraindicated</strong> in bilateral renal stenosis as they can <strong>precipitate acute renal failure</strong> due to dilation of efferent arterioles and fall in glomerular filtration pressure.</p>\n<p>Patient 4: <strong>ACE inhibition</strong> in patients with systolic dysfunction prevents or <strong>delays</strong> the progression of <strong>heart failure</strong>, <strong>decreases</strong> the incidence of <strong>sudden death</strong> and <strong>myocardial infarction</strong>, and improves the quality of life. ACE inhibition reduces afterload and systolic wall stress, and both cardiac output and cardiac index increase.</p>\n<p>Patient 5: The use of ACE inhibitors considerably improves the survival of patients with scleroderma renal crisis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4709",
      "difficulty": "easy"
    },
    {
      "text": "A 53-year-old hypertensive patient has been on ACE inhibitors for the last 12 years. Which of the following effects would you expect to see in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Rightward shift in renal pressure natriuresis curve"
        },
        {
          "id": 2,
          "text": "Reduction in filtration fraction"
        },
        {
          "id": 3,
          "text": "Significant increase in heart rate"
        },
        {
          "id": 4,
          "text": "Decrease in compliance of large arteries"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>ACE inhibitors,</strong> when used for a long time in patients with hypertension, cause<strong>&nbsp;</strong>a<strong> reduction in filtration fraction.</strong></p>\n<p>Filtration fraction is the ratio of GFR to that of renal plasma flow. ACE inhibitors <strong>increase renal blood flow</strong> without altering GFR and thus result in reduction of filtration fraction.</p>\n<p>Option A:&nbsp;The graph plotted between urinary sodium excretion and mean blood pressure is known as the <strong>pressure natriuresis curve.</strong> For example, when dietary sodium intake is low, renin release is stimulated. <strong>Angiotensin II</strong> acts on the kidneys to shift the renal pressure &ndash; natriuresis curve to the <strong>right. </strong>This&nbsp;increases sodium and water retention.&nbsp;</p>\n<p>Conversely, when dietary Na+ is high or when ACE inhibitors are used, there is the <strong>withdrawal of angiotensin II</strong>. The renal pressure natriuresis curve shifts to the <strong>left.</strong></p>\n<p>The following image depicts a pressure natriuresis curve:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2612147181bf421c80443ad4c6b7cb6bx1280x1347.JPEG\" alt=\"Explanation Image\"><p>Options C and D: ACE inhibitors do not cause a significant increase in heart rate and can have a <strong>favorable change</strong> in the <strong>compliance of large arteries</strong> on long-term use.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4697",
      "difficulty": "medium"
    },
    {
      "text": "A patient who is started on lisinopril for hypertension is concerned about its adverse effects. Which among the following is not an adverse effect of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Dysgeusia"
        },
        {
          "id": 2,
          "text": "Hypokalemia"
        },
        {
          "id": 3,
          "text": "Neutropenia"
        },
        {
          "id": 4,
          "text": "Skin rash"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>ACE inhibitors </strong>are associated with the development of <strong>hyperkalemia</strong>.</p>\n<p>Hyperkalemia occurs due to the inhibition of angiotensin II-mediated aldosterone secretion. Decreased aldosterone levels result in decreased tubular excretion of potassium in the kidneys leading to hyperkalemia.</p>\n<p>The adverse effects of ACE inhibitors are:</p>\n<ul>\n<li>Hypotension</li>\n<li>Hyperkalemia</li>\n<li>Cough</li>\n<li>Angioedema</li>\n<li><strong>Skin rash</strong></li>\n<li>Teratogenicity</li>\n<li><strong>Dysgeusia</strong> (alteration in or loss of taste)</li>\n</ul>\n<div class=\"page\" title=\"Page 495\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Extremely rare but reversible side effects include <strong>neutropenia</strong>, glycosuria in the absence of hyperglycemia, anemia, and hepatotoxicity.</p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4700",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents to the casualty with cough, difficulty in breathing, and non-indurating edema of his face and lips. He had recently been started on ramipril for hypertension. Which among the following mediates these adverse effects?",
      "choices": [
        {
          "id": 1,
          "text": "Bradykinin and renin"
        },
        {
          "id": 2,
          "text": "Angiotensin II and bradykinin"
        },
        {
          "id": 3,
          "text": "Only bradykinin"
        },
        {
          "id": 4,
          "text": "Histamine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario is suggestive of <strong>ACE inhibitor-induced angioedema</strong> which occurs due to <strong>bradykinin.</strong></p>\n<p>Angioedema is most commonly mediated by histamine. However, bradykinin-mediated angioedema, though less common, can result due to hereditary or acquired <strong>defects in C1 esterase inhibitor</strong> and as a side effect of ACE inhibitors.</p>\n<p>ACE has structural similarity to another enzyme called <strong>kininase</strong>. Kininase normally <strong>metabolizes bradykinin</strong>, substance P, and prostaglandins. <strong>ACE inhibitors</strong> when administered also <strong>block kininase</strong> enzyme which results in an increase in the concentration of these substrates. An&nbsp;<strong>increase </strong>in the level of <strong>bradykinin/ substance P </strong>levels&nbsp;results in <strong>persistent brassy cough </strong>and<strong> angioedema</strong> in the patients.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4701",
      "difficulty": "medium"
    },
    {
      "text": "An 18-year-old boy is brought to the casualty with complaints of swelling of his face and lips as shown in the image below. On further enquiry, it is noted that he has suffered from similar episodes in the past whenever he becomes emotional. He is prescribed icatibant. What is the likely mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Bradykinin B2 receptor agonist"
        },
        {
          "id": 2,
          "text": "Bradykinin B2 receptor antagonist"
        },
        {
          "id": 3,
          "text": "Bradykinin B1 receptor agonist"
        },
        {
          "id": 4,
          "text": "Bradykinin B1 receptor antagonist"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario and image showing swelling of the face and lips is suggestive of<strong>&nbsp;hereditary angioedema</strong>.<strong> Icatibant </strong>is a<strong> selective bradykinin B<sub>2</sub> receptor </strong>competitive <strong>antagonist</strong>&nbsp;indicated for the treatment of acute attacks of hereditary angioedema.</p>\n<p>The other drug which is approved for the treatment of&nbsp;acute attacks of hereditary angioedema is <strong>ecallantide&nbsp;</strong>which is a <strong>synthetic plasma kallikrein inhibitor</strong>. Both these drugs are <strong>administered subcutaneously</strong>.</p><p>The&nbsp;U.S. Food and Drug Administration (FDA) has recently approved another plasma kallikrein inhibitor,&nbsp;<strong>berotralstat</strong>, as the <strong>first oral drug</strong> for the prevention and treatment of hereditary angioedema.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5ec1504cc1c8408485f6e571e4ee5172.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7446",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old diabetic male is on ACE inhibitors for hypertension. Which among the following is the most serious adverse effect you would expect to see in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Hypotension"
        },
        {
          "id": 2,
          "text": "Hypokalemia"
        },
        {
          "id": 3,
          "text": "Hypocalcemia"
        },
        {
          "id": 4,
          "text": "Hypercalcemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most significant <strong>adverse effect</strong>&nbsp;seen with the use of ACE inhibitors is <strong>hypotension.</strong></p>\n<p>ACE inhibitors are used in the management of hypertension and are one of the first-line drugs for this condition.<strong>&nbsp;</strong></p>\n<div class=\"page\" title=\"Page 494\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option B: ACE inhibitors may cause <strong>hyperkalemia</strong> in patients with renal insufficiency or diabetes.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Options C and D: ACE inhibitors <strong>do not affect calcium levels</strong> significantly.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4699",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old man is diagnosed with hypertension and is prescribed losartan. Which of the following statements about the drug is incorrect?",
      "choices": [
        {
          "id": 1,
          "text": "It is a competitive angiotensin receptor antagonist"
        },
        {
          "id": 2,
          "text": "It attenuates platelet aggregation"
        },
        {
          "id": 3,
          "text": "Associated with negligible cough"
        },
        {
          "id": 4,
          "text": "Causes hyperuricemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Losartan </strong>use is not associated with hyperuricemia. In fact, losartan is <strong>uricosuric</strong> and can also be <strong>used in</strong> patients with <strong>gout</strong>.</p>\n<p>Losartan is a competitive <strong>angiotensin II receptor antagonist</strong>. It binds to the AT<sub>1</sub> receptor with high affinity. it is also a<strong> competitive antagonist</strong> of the <strong>thromboxane A2 receptor</strong> and attenuates platelet aggregation. Losartan has no effect on ACE and it does <strong>not inhibit bradykinin breakdown</strong>. This results in negligible incidences of cough.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4710",
      "difficulty": "medium"
    },
    {
      "text": "Combined use of ACE inhibitors and ARBs are not routinely indicated primarily due to the increased risk of which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperkalemia"
        },
        {
          "id": 2,
          "text": "Hypokalemia"
        },
        {
          "id": 3,
          "text": "Angioedema"
        },
        {
          "id": 4,
          "text": "Heart failure"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>combined</strong> use of <strong>ACE inhibitors and ARBs</strong> are not commonly indicated as they increase the risk of<strong> hyperkalemia.&nbsp;</strong></p>\n<p>They also increase the risk of <strong>hypotension</strong> and <strong>renal injury</strong>. Any such use should be done under the supervision of specialists with frequent monitoring.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2152",
      "difficulty": "medium"
    }
  ]
}